you don't seem to be taking into account the trailing payments from pharma's for share of market saved from generic competition an unknown dollar amount as the percentage of market saved cannot be known at this stage would it be to much to suggest this makes your guesses really conservative at this time
you don't seem to be taking into account the trailing payments...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)